Laddar...
Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials
In vivo imaging of the tau protein has the potential to aid in quantitative diagnosis of Alzheimer’s disease, corroborate or dispute the amyloid hypothesis, and demonstrate biomarker engagement in clinical drug trials. A host of tau positron emission tomography agents have been designed, validated,...
Sparad:
| I publikationen: | Neurotherapeutics |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer US
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5233632/ https://ncbi.nlm.nih.gov/pubmed/27873182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0490-y |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|